NCT07139327View on ClinicalTrials.gov

A Pivotal Study to Evaluate the Efficacy and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

NANot yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

October 31, 2027

Conditions
Hearing Loss, Bilateral Sensorineural
Interventions
DEVICE

Cochlear Implant

TICI G2 Clinical Investigation System

Trial Locations (5)

2050

Royal Prince Alfred Hospital, Camperdown

2145

Westmead Hospital, Westmead

3002

Royal Victoria Eye and Ear Hospital, East Melbourne

38700

Centre Hospitalier Universitaire Grenoble Alpes, La Tronche

59000

Centre Hospitalier Universitaire de Lille, Lille

Sponsors

Lead Sponsor

Cochlear
All Listed Sponsors
lead

Cochlear

INDUSTRY

NCT07139327 - A Pivotal Study to Evaluate the Efficacy and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults | Biotech Hunter | Biotech Hunter